Derek Adams
Direktor/Vorstandsmitglied bei ALLOVIR, INC.
Vermögen: 28 000 $ am 30.04.2024
Aktive Positionen von Derek Adams
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALLOVIR, INC. | Direktor/Vorstandsmitglied | 01.03.2023 | - |
| Independent Dir/Board Member | 01.03.2023 | - |
Karriereverlauf von Derek Adams
Ehemalige bekannte Positionen von Derek Adams
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Vorstandsvorsitzender | 01.03.2022 | 01.11.2022 |
| Geschäftsführer | 08.07.2021 | - | |
| Präsident | 01.03.2022 | 01.11.2022 | |
| BLUEBIRD BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.03.2017 | 01.07.2021 |
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 01.02.2016 | 01.06.2016 |
| ALEXION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2015 | 01.02.2016 |
Ausbildung von Derek Adams
| University of Minnesota | Doctorate Degree |
| Worcester Polytechnic Institute | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| ALLOVIR, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
- Börse
- Insiders
- Derek Adams
- Erfahrung
